Evidence map›Paper›PMID 29756064›Full record

ReviewRomanian journal of anaesthesia and intensive care2018

Neuromuscular monitoring: an update.

Mădălina Duţu, Robert Ivaşcu, Oana Tudorache, Darius Morlova, Alina Stanca, Silvius Negoiţă, Dan Corneci

Registry-linked trialAbstract readReview
In one paragraph

Review in Romanian journal of anaesthesia and intensive care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04762420 (Sugammadex Dosing), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04762420 completednot on this mapstarted 2019, after this paper: background citation

Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring

TypeobservationalSponsorHospital do Divino Espírito Santo de Ponta DelgadaRan2019 to 2019Enrolled66ConditionsNeuromuscular Blockade, Anesthesia, TOF, Curarization, Postoperative ResidualArmsDose of sugammadex according to SSD and QSD
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Neuromuscular blocking agents in the intensive care unit.The Journal of international medical research · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mădălina DuţuAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.
Robert IvaşcuAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.
Oana TudoracheAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.
Darius MorlovaAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.
Alina StancaAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.
Silvius NegoiţăAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.
Dan CorneciAnaesthesiology and Critical Care Department, Elias Clinical Emergency Hospital, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review makes an advocacy for neuromuscular blockade monitoring during anaesthesia care, by: (i) describing the fundamental principles of the methods currently available, at the same time emphasizing quantitative recording measurements; (ii) describing the different ways in which muscles respond to the effect of neuromuscular blockade and their use in clinical practice; (iii) presenting results of different studies on timing and agents of neuromuscular block reversal, including a recommendation for sugammadex use and experimental results with calabadion and (iv) in the end emphasizing the need for implementing neuromuscular monitoring as a practice that should be used every time a neuromuscular block is required.

Indexed as

calabadionneuromuscular monitoringperipheral nerve stimulatorquantitative monitoringresidual neuromuscular blockadesugammadex

Identifiers

PMID29756064
PMCPMC5931185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.